Add to ORKGNatalizumab (Tysabri ® by Biogen Idec) is a human-ized monoclonal antibody indicated for the treatment of active relapsing–remitting multiple sclerosis (RRMS), and Crohn’s disease. It acts as an immu
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...
Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, ...
Copyright © 2015 Massimiliano Castellazzi et al.This is an open access article distributed under the...
Natalizumab is a humanized monoclonal antibody that binds the cellular adhesion molecule α4-integrin...
Natalizumab (NTZ) is a humanized anti-α4 integrin monoclonal antibody approved for relapsing–remitti...
Alemtuzumab is a humanized monoclonal anti-body therapy for relapsing-remitting multiple scle-rosis ...
Multiple sclerosis (MS) is a chronic, progressive autoimmune disease that can lead to neurological i...
Multiple sclerosis (MS) is a chronic autoim-mune inflammatory disease of the central nerv-ous system...
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...
Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, ...
Copyright © 2015 Massimiliano Castellazzi et al.This is an open access article distributed under the...
Natalizumab is a humanized monoclonal antibody that binds the cellular adhesion molecule α4-integrin...
Natalizumab (NTZ) is a humanized anti-α4 integrin monoclonal antibody approved for relapsing–remitti...
Alemtuzumab is a humanized monoclonal anti-body therapy for relapsing-remitting multiple scle-rosis ...
Multiple sclerosis (MS) is a chronic, progressive autoimmune disease that can lead to neurological i...
Multiple sclerosis (MS) is a chronic autoim-mune inflammatory disease of the central nerv-ous system...
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...
Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, ...
Copyright © 2015 Massimiliano Castellazzi et al.This is an open access article distributed under the...